| European Case Law Identifier: | ECLI:EP:BA:2014:T007510.20140120 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 20 January 2014 | ||||||||
| Case number: | T 0075/10 | ||||||||
| Application number: | 01115854.0 | ||||||||
| IPC class: | A61K 31/135 A61P 25/22 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | New treatments using phenethylamine derivatives | ||||||||
| Applicant name: | Wyeth LLC | ||||||||
| Opponent name: | EGIS Gyógyszergyár Nyrt | ||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: | |||||||||
| Keywords: | Admissibility of appeal (yes) Duly exercise of discretion by opposition division under Article 114(2) EPC (yes) Substantive procedural violation of right to be heard under Article 113(1) EPC (yes) Remittal |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t100075eu1.html
Date retrieved: 17 May 2021